Jiangao Pediatrics
A child growth and development management medical institution
About Jiangao Pediatrics
Jiangao Pediatrics (健高儿科) is a specialized medical service provider in China, focusing on the growth and development of children and adolescents. The company operates a chain of pediatric clinics, with its first outpatient department established in Shanghai in 2007. It has since expanded its presence to major cities including Beijing, Hangzhou, Wuhan, and Chengdu, operating over 27 clinics across 12 provinces.
The corporate entity, Jian Gao Medical Technology (Shanghai) Co., Ltd., was formally established on December 12, 2018. The company is chaired by Wu Zhijun, who also serves as the chairman of Juneyao Health. Jiangao Pediatrics is a key part of the Juneyao Group's healthcare segment, with Shanghai Juneyao Medical Health Technology Co., Ltd. being the majority shareholder.
The business centers on providing comprehensive management of children's developmental health. Its services are targeted at infants, children, and adolescents, addressing a range of needs from general health management to specialized diagnostics and treatment. The clinics offer services such as height management, diagnosis and treatment for dwarfism and precocious puberty, health management for high-risk premature infants, and psychological counseling for infants. By adopting a model that integrates multi-disciplinary approaches across the entire growth cycle, the company aims to deliver a one-stop, high-quality service. Revenue is generated directly from the medical and consulting services provided at its chain of clinics.
Jiangao Pediatrics has successfully secured significant funding to support its expansion. In August 2021, it received a strategic investment of 28 million RMB from Wuxi Dazhong Oriental Co., Ltd. This was followed by a larger strategic financing round of 81.36 million RMB in July 2022, led by Juneyao Medical, an affiliate of the Juneyao Group.
Source: Dealroom company dataNews
Open roles
Jiangao Pediatrics in the Jing'an District ecosystem
The Jiangao Pediatrics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
- GHGreat Eastern Holdings
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Jiangao Pediatrics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Jiangao Pediatrics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

